Wan-jing Ding

发表

E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα

Ning Zhang, Qiaojun He, Bo Yang, 2014, Cell cycle.

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Retinoid agonistAm80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model

Qiaojun He, N. Prasadarao, Lingtao Wu, 2017 .

Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.

Qiaojun He, N. Prasadarao, Lingtao Wu, 2013, Blood.

Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells

W. Lu, Qiaojun He, Bo Yang, 2012, PloS one.

Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol

Qiaojun He, Hong Zhu, Qinjie Weng, 2010, Cancer investigation.

GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.

Qiaojun He, Bo Yang, N. Lin, 2011, Cancer letters.

XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.

Qiaojun He, Bo Yang, Yongzhou Hu, 2009, Cancer letters.

Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity

Qiaojun He, W. May, Lingtao Wu, 2012, Oncogene.

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

W. Lu, Qiaojun He, Bo Yang, 2010, Cancer letters.

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

W. Lu, Qiaojun He, Bo Yang, 2010, Cancer letters.

HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia.

Qiaojun He, Bo Yang, Ji Cao, 2010, Pharmacological research.